Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
35,580,325
-
Share change
-
+34,784
-
Total reported value
-
$1,198,097,570
-
Put/Call ratio
-
286%
-
Price per share
-
$33.91
-
Number of holders
-
179
-
Value change
-
+$5,031,601
-
Number of buys
-
99
-
Number of sells
-
72
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2017
As of 30 Jun 2017,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
179 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,580,325 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, ABERDEEN ASSET MANAGEMENT PLC/UK, GLENMEDE TRUST CO NA, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, SNYDER CAPITAL MANAGEMENT L P, Invesco Ltd., and ROYAL BANK OF CANADA.
This page lists
178
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.